Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300275
- Awardee
-
Pierce Biotechnology Inc. UEI CCSJMTEVB1V7 Part of Thermo Electron Corporation
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,139
Award facts
- Contract value 100% obligated
- $4,139.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockford, IL 61105, USA
Award details come from SAM.gov/FPDS.
About this award
Pierce Biotechnology Inc., a subsidiary of Thermo Electron Corporation, received a contract award from a civilian federal agency on July 9, 2014, for drugs and biologicals under a Blanket Purchase Agreement (BPA) call mechanism. The contract carries a ceiling value of $4,139.36 and employs firm fixed price pricing. The work will be performed in Rockford, Illinois. This award was made without a set-aside designation, reflecting Pierce Biotechnology's status as an established contractor capable of meeting federal requirements. The contract is scheduled for ultimate completion by February 28, 2015.
As a subsidiary of Thermo Electron Corporation's Financial Services Division, Pierce Biotechnology leverages its parent company's extensive expertise in providing scientific instruments and biologics to federal agencies. Thermo Electron maintains significant indefinite delivery vehicles with agencies including the Food and Drug Administration and Naval Sea Systems Command, positioning its subsidiaries like Pierce Biotechnology to efficiently fulfill task orders for specialized products and services. This BPA call award represents a procurement action that draws upon the established relationship and infrastructure between Pierce Biotechnology and the federal government for the delivery of pharmaceutical and biological products.
Quick answers
Who was awarded contract HHSN26300275?
HHSN26300275 was awarded to Pierce Biotechnology Inc. by Office of the Director (National Institutes of Health) on July 9, 2014.
How much is contract HHSN26300275 worth?
The government has obligated $4,139 on HHSN26300275.
Is contract HHSN26300275 an order under another contract?
Yes. HHSN26300275 is a BPA call under HHSN263199800049380B, a blanket purchase agreement.
Was contract HHSN26300275 competed?
The extent of competition for HHSN26300275 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award